Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | OLFML2B |
| Upstream (Parents) |
|---|
| (<<) FSTL1 → OLFML2B |
| (<<) VIM → OLFML2B |
| (<<) PRRX1 → OLFML2B |
| (<<) KAL1 → OLFML2B |
| (<<) RAB31 → OLFML2B |
| Downstream (Children) |
|---|
| OLFML2B → PCDHGA3 (>>) |
| OLFML2B → CHST1 (>>) |
| OLFML2B → COL16A1 (>>) |
| OLFML2B → EGFL6 (>>) |
| OLFML2B → ABI3BP (>>) |
| OLFML2B → HIGD1B (>>) |
| OLFML2B → FZD2 (>>) |
| OLFML2B → TNFRSF4 (>>) |
| OLFML2B → ITGB3 (>>) |
| OLFML2B → PRRX1 (>>) |
| OLFML2B → BNC2 (>>) |
| OLFML2B → KAL1 (>>) |
| OLFML2B → DCLK1 (>>) |
| OLFML2B → SBNO2 (>>) |
| OLFML2B → AKR1C3 (>>) |
| OLFML2B → FMNL1 (>>) |
| OLFML2B → PDZRN3 (>>) |
| OLFML2B → LPAR1 (>>) |
| OLFML2B → GHRH (>>) |
